(1) Background: Perfluorodecanoic acid (PFDA), a persistent perfluoroalkyl obesogen, promotes adipogenesis, yet whether its effects can be pharmacologically opposed remains unknown. (2) Methods: We examined the interaction between PFDA (50, 75 μM) and the dietary polyphenol curcumin (20, 30 μM) throughout the 8-day 3T3-L1 preadipocyte differentiation protocol, using cell-viability (WST-1) assays with a two-factor interaction analysis, Oil Red O lipid quantification and mRNA profiling of Pparg, Cebpa, Srebf1, and Fasn. (3) Results: PFDA alone increased lipid accumulation and upregulated Pparg, Cebpa, and Fasn, whereas Srebf1 was induced only weakly and only at the higher dose, a pattern compatible with preferential engagement of the PPARγ/C/EBPα program over the SREBP-1c lipogenic pathway at the mRNA level, although the transcripts were not formally compared and no protein-level data were obtained. At two sub-cytotoxic concentrations, curcumin preserved potent antiadipogenic activity, reducing lipid accumulation by up to 67.3% and reversing PFDA-induced gene upregulation. At the viability endpoint the two compounds acted independently: curcumin significantly reduced viability and PFDA significantly increased it, with no statistically detectable interaction between them (two-way ANOVA, interaction p = 0.85). (4) Conclusions: This dissociation shows that a chemical interaction defined at one biological endpoint does not predict its outcome at another, a principle with broad implications for mixture toxicology—and it establishes curcumin as a candidate dietary intervention that intercepts an obesogen’s transcriptional program against environmentally driven metabolic disruption.
30 September 2026 in Journal of Basic and Clinical Health Sciences
Purpose: SIRT1 functions in regulatory mechanisms including cellular aging, apoptosis, glucose and lipid metabolism, oxidative stress and inflammation. Studies show that SIRT1 inhibitors may affect various types of cancer and metabolic disorders, making SIRT1 an important therapeutic target. Boric acid is an inorganic boron compound with antimicrobial, antifungal and potential anticancer effects. Calcium fructoborate, another boron compound found in vegetables and fruits, has anti-inflammatory, antioxidant and anti-tumor effects. This study aimed to investigate the inhibitory potential of calcium fructoborate on SIRT1 activity and to evaluate its possible use as a chemical tool for future studies targeting SIRT1 regulation.Material and Methods: In this study, the effect of calcium fructoborate on SIRT1 activity was investigated by a fluorescence-based method using human recombinant SIRT1.Results: Calcium fructoborate inhibited SIRT1 activity in a dose-dependent manner. Calcium fructoborate significantly inhibited SIRT1 activity by 42% at a concentration of 20 mM (p < 0.001). In the boric acid group, a decreasing trend in SIRT1 enzyme activity was observed, but this difference was not statistically significant.Conclusion: The results provide important basic information. Calcium fructoborate may be used as a chemical tool to elucidate the biological functions of SIRT1 and to investigate the potential therapeutic applications of SIRT1 inhibitors.
29 April 2024 in Turkish Journal of Diabetes and Obesity